SCHEMBL7128930

SCHEMBL7128930

Cc1cnc(NC(=O)c2cc([N+](=O)[O-])ccc2Cl)s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 7/20 0.59
SMN1; SMN2 Q16637 5/20 0.57
CYP3A4 P08684 2/20 0.57
MAPK1 P28482 2/20 0.57
PPARG P37231 2/20 0.57
ALOX15 P16050 1/20 0.57
PPARA Q07869 1/20 0.57
KMT2A Q03164 5/20 0.57
MEN1 O00255 4/20 0.57
GAA P10253 2/20 0.57
POLB P06746 1/20 0.57
HTT P42858 2/20 0.56
MAPT P10636 3/20 0.56
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
PKM P14618 1/20 0.56
TSHR P16473 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7126974 0.86 SMN1; SMN2 (0.57) RORCSMN1; SMN2CYP3A4MAPK1PPARG
SCHEMBL5713417 0.86 MITF (0.50) SMN1; SMN2KMT2AMEN1MAPTLMNA
SCHEMBL31110207 0.86 STAT3 (0.54) SMN1; SMN2KMT2AMEN1POLBMAPT
SCHEMBL5836520 0.85 SMN1; SMN2 (0.54) RORCSMN1; SMN2CYP3A4MAPK1PPARG
SCHEMBL343933 0.83 RAB9A (0.58) SMN1; SMN2CYP3A4KMT2AMEN1GAA
SCHEMBL7130981 0.82 MAPT (0.62) RORCSMN1; SMN2CYP3A4MAPK1PPARG
SCHEMBL7128392 0.79 SMN1; SMN2 (0.65) RORCSMN1; SMN2CYP3A4MAPK1PPARG
SCHEMBL7119948 0.78 SMN1; SMN2 (0.83) RORCSMN1; SMN2CYP3A4MAPK1PPARG
SCHEMBL24074066 0.77 SMN1; SMN2 (0.72) SMN1; SMN2MAPK1KMT2AMEN1GAA
SCHEMBL7132352 0.77 SMN1; SMN2 (0.60) RORCSMN1; SMN2CYP3A4MAPK1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD RORC 67/4885SMN1; SMN2 3743/4885CYP3A4 1516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.